Serum BCMA to Determine Disease Progression in RRMM Patients

Serum BCMA to Determine Disease Progression in RRMM Patients Sponsor: Incyte Protocol Number: I-RUX-19-52 Start…

Read More

A Pilot Study Examining Selinexor’s Ability to Overcome Resistance in Multiple Myeloma Patients Who Are Refractory to Lenalidomide-containing Therapy

A Pilot Study Examining Selinexor’s Ability to Overcome Resistance in Multiple Myeloma Patients Who Are…

Click for Study Read More

A Randomized Phase 2 Study of Peri-Operative Ipilimumab, Nivolumab and Cryoablation Versus Standard Peri-Operative Care in Women

A Randomized Phase 2 Study of Peri-Operative Ipilimumab, Nivolumab and Cryoablation Versus Standard Peri-Operative Care…

Click for Study Read More

Neoadjuvant Her2-targeted Therapy and Immunotherapy with Pembrolizumab

Neoadjuvant Her2-targeted Therapy and Immunotherapy with Pembrolizumab Sponsor: Merck/Cedars-Sinai Protocol Number: 2018-04-McArthur-neoHP Start Date: 11/15/2019…

Click for Study Read More

A Phase 2 Study of Weekly 70 mg/m2 Carfilzomib for Multiple Myeloma Patients Refractory to 27 mg/m2 Carfilzomib

 A Phase 2 Study of Weekly 70 mg/m2 Carfilzomib for Multiple Myeloma Patients Refractory to…

Click for Study Read More

A Phase 2 Trial of the Efficacy and Safety of Elotuzumab in Combination with Pomalidomide, Carfilzomib and Dexamethasone

A Phase 2 Trial of the Efficacy and Safety of Elotuzumab in Combination with Pomalidomide,…

Click for Study Read More

A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients

A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients Sponsor: Incyte Protocol…

Click for Study Read More

A Phase 2 Study of Pomalidomide as a Replacement for Lenalidomide for Multiple Myeloma Patients

A Phase 2 Study of Pomalidomide as a Replacement for Lenalidomide for Multiple Myeloma Patients…

Click for Study Read More

Recombinant Human Arginase 1 (rhArg1)

Recombinant Human Arginase 1 (rhArg1) in Patients With Advanced Arginine Auxotrophic Solid Tumors: Dose Escalation,…

Click for Study Read More

A Phase 2, Open Label, Randomized Trial Evaluating Ixazomib Compared to Ixazomib-Lenalidomide

A Phase 2, Open Label, Randomized Trial Evaluating Ixazomib Compared to Ixazomib-Lenalidomide Combination Maintenance Therapy…

Click for Study Read More